In remarks scheduled today for Chief Technology Officer Robb Fraley at Farm Progress Show in Decatur, Ill., Monsanto Company (NYSE: MON) will announce that, in light of current demand, the company and its licensing partners expect to have a supply of Roundup Ready 2 Xtend® soybeans for up to half of all U.S. soybean acres for the 2018 season, doubling what is planted this season.

Fraley will emphasize several business milestones today as he addresses grower groups and media attending the annual Farm Progress Show.

Roundup Ready 2 Xtend® Soybeans

"We are hearing that the overwhelming majority of farmers using Monsanto's low-volatility dicamba product, XtendiMax® herbicide with VaporGrip® technology, this year are experiencing tremendous success. In states where we sold our dicamba product this season, we have heard some reports of leaf cupping, which can have many possible causes," Fraley says. "In the vast majority of situations, we have identified issues that are addressable through training and following the label instructions, and we continue to hear from many farmers that our training and education efforts helped them use the technology successfully this season."

To date, Monsanto has directly worked with nearly 50,000 farmers and applicators at XtendiMax® herbicide with VaporGrip® technology learning events across the country and will continue to evolve and tailor trainings to continue to help growers use this new technology successfully. Fraley will acknowledge the ongoing discussions about in-crop use of new dicamba formulations.

"We understand that EPA is working with the states and is evaluating potential actions to facilitate enhanced training and compliance for 2018. We are communicating with the EPA, which is interested in achieving national uniformity with dicamba regulation to avoid a state patchwork," he says. "I've seen first-hand that the Roundup Ready 2 Xtend® soybean crop is developing well and I look forward to partnering with growers through harvest."

Fraley will underscore the milestones hit in the initial launch year of the Roundup Ready Xtend® Crop System, including EPA approval for in-crop use of XtendiMax® herbicide with VaporGrip® technology and for numerous tank mix partners, including glyphosate, and the availability of more than 120 Roundup Ready 2 Xtend soybean varieties across all relative maturity zones, more than ten times the products compared to the Roundup Ready 2 Yield® soybeans launch.

Monsanto now expects that, together with its partners, it will have supply for up to roughly half of the U.S. soybean market next year, following a season where more than 20 million acres were planted, on the way to a market opportunity of 200-250 million acres globally.

"Based on the great demand we've seen, we know farmers are looking forward to the benefits of the Roundup Ready Xtend Crop System," he says. "Growers have been asking for this technology for years, and we're excited to be able to provide it again in 2018."

The Roundup Ready Xtend Crop System is designed to provide farmers with more consistent, flexible control of weeds, especially tough-to-manage and glyphosate resistant weeds, and to help maximize crop yield potential. The system includes Roundup Ready 2 Xtend soybeans, the industry's first biotech product with tolerance to dicamba and glyphosate herbicides, and Bollgard II® XtendFlex®, providing tolerance to three herbicides, dicamba, glyphosate and glufosinate.

The Climate Corporation

Fraley will also express confidence in the advancement of digital agriculture tools, as The Climate Corporation publicly announces seven product advancements in an industry-leading research pipeline of more than 35 projects, including key advancements in fertility and seed scripting, as well as corn disease diagnosis. Key enhancements, to be announced in detail later today, will enable more farmers to experience the value of the Climate FieldView TM platform.

"The Climate team has several robust research initiatives underway, and we continue investing heavily in accelerating the speed of innovation to bring farmers more advanced insights more quickly," Fraley notes. "Our R&D innovation spans our entire organization, including science, technology, engineering and analytics. By expanding our science-backed, data-driven analytics capabilities and applying them to our growing streams of field data, we continue to discover never-before-seen insights that advance FieldView for farmers."

For more information and the full news release on Climate FieldView TM, visit

NemaStrike TM Technology

Fraley also predicts that future advances in agriculture may come from the control of the invisible, as evidenced by the company's breakthrough product in nematode control, NemaStrike TM Technology. Monsanto now offers NemaStrike TM Technology by Acceleron ® Seed Applied Solutions as a game-changing solution to control the invasive nematode problem causing greater than 10 percent yield loss in corn, soybeans and cotton. As a broad-spectrum nematicide, NemaStrike Technology is designed to strike in the root zone where nematodes attack while providing consistent yield protection. This technology stands apart as a means to protect yield.

"The launch of NemaStrike Technology is exciting because the technology provides broad-spectrum control of plant parasitic nematodes in corn, soybeans, and cotton," Fraley says. "Today, many growers underestimate the severe impact nematodes have on yield and overall crop health. NemaStrike Technology addresses this important unmet need."

For more information on Farm Progress Show conversations and engagements, follow the conversation on Twitter at @RobbFraley or @MonsantoCo, #FPS17.

About Monsanto Company

Monsanto is committed to bringing a broad range of solutions to help nourish our growing world. We produce seeds for fruits, vegetables and key crops - such as corn, soybeans, and cotton - that help farmers have better harvests while using water and other important resources more efficiently. We work to find sustainable solutions for soil health, help farmers use data to improve farming practices and conserve natural resources, and provide crop protection products to minimize damage from pests and disease. Through programs and partnerships, we collaborate with farmers, researchers, nonprofit organizations, universities and others to help tackle some of the world's biggest challenges. To learn more about Monsanto, our commitments and our more than 20,000 dedicated employees, please visit Follow our business on Twitter ® at

Cautionary Statements Regarding Forward-Looking Information: Certain statements contained in this release are "forward-looking statements," such as statements concerning the company's anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts, as well as the pending transaction with Bayer Aktiengesellschaft ("Bayer"). These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: risks related to the pending transaction between the company and Bayer, including the risk that the regulatory approvals required for the transaction may not be obtained on the anticipated terms or time frame or at all, the risk that the other conditions to the completion of the transaction may not be satisfied, the risk that disruptions or uncertainties related to the pending transaction could adversely affect the company's business, financial performance and/or relationships with third parties, and the risk that certain contractual restrictions during the pendency of the transaction could adversely affect the company's ability to pursue business opportunities or strategic transactions; continued competition in seeds, traits and agricultural chemicals; the company's exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public understanding and acceptance of our biotechnology and other agricultural products; the success of the company's research and development activities; the outcomes of major lawsuits, including potential litigation related to the pending transaction with Bayer; developments related to foreign currencies and economies; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company's estimates related to distribution inventory levels; the recent increases in levels of indebtedness, continued availability of capital and financing and rating agency actions; the company's ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters, accidents, and security breaches, including cybersecurity incidents, on the agriculture business or the company's facilities; and other risks and factors detailed in the company's most recent periodic report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.

View source version on

Copyright Business Wire 2010